AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company's revenues decreased by
ANGO Earnings: A snapshot of AngioDynamics’ Q1 2025 results
AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company's revenues decreased by double-digit during the three months. Net loss, excluding special items, was $0.11 per share in the August quarter,